TwinBeech Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.4M | Buy |
+299,229
| New | +$16.4M | 0.37% | 80 |
|
2024
Q4 | – | Sell |
-320,287
| Closed | -$22.5M | – | 632 |
|
2024
Q3 | $22.5M | Buy |
+320,287
| New | +$22.5M | 0.43% | 60 |
|
2023
Q1 | – | Sell |
-100,053
| Closed | -$10.4M | – | 625 |
|
2022
Q4 | $10.4M | Sell |
100,053
-61,870
| -38% | -$6.4M | 0.2% | 146 |
|
2022
Q3 | $13.7M | Buy |
+161,923
| New | +$13.7M | 0.36% | 88 |
|
2021
Q2 | – | Sell |
-15,874
| Closed | -$1.2M | – | 455 |
|
2021
Q1 | $1.2M | Buy |
15,874
+8,900
| +128% | +$672K | 0.18% | 171 |
|
2020
Q4 | $612K | Buy |
+6,974
| New | +$612K | 0.1% | 259 |
|